Ola Landgen, MD, PhD | Authors


Dr. Ola Landgren on Three-Drug Treatments and the Use of Monoclonal Antibodies

December 09, 2015

Ola Landgren, MD, PhD, on the progression treatments from combinations toward three-drug treatments and the use of monoclonal antibodies. Landgen adds that while he does have faith that monoclonal antibodies will change the treatment landscape in oncology, he says they could very well be combined with old and new drugs.